Ensuring the health and productivity of starter cattle is a complex challenge. One of the critical aspects of managing this is understanding and supporting their immune systems, especially during the stressful transition from pasture to backgrounder or feedlot.

Today’s beef industry is moving through uncharted territory. Record prices are being recorded for finished animals, weaned calf dollar amounts have never been higher, and more younger calves are entering feedlots than ever before.

Developing replacement heifers is one of the most expensive and complex management decisions for a cow-calf producer and also has long-term implications for profitability.

As we near the feedlot fall run and cow-calf producers market their calves at the highest prices received to date, every additional pound of gain has greater profit potential.

Did you know that every three hours, a vehicle or person is hit by a train in the U.S.? Annually, more than 2,300 people are injured or killed in railroad crossing or trespass incidents throughout North America.

After a busy season of breeding, pulling bulls, pregnancy diagnosis and weaning, we’d like to hope cows can turn on autopilot for a few months during the winter. However, that’s not the case; cows are always working for us, whether that means lactating, raising a calf, preparing to become pregnant or gestating next year’s calf. It’s our responsibility to make sure they are in the proper body condition to do so.

In a recent article put out by the USDA, studies show beef cow-calf production continues to be a lifestyle choice for some farmers. The 2022 USDA Census reported 85% of the total U.S. cattle operations are cow-calf or seedstock, and the majority of these operations are small scale, with 55% having fewer than 20 cows.

Whether they’re man-made or natural disasters, emergencies such as tornados, hurricanes, wildfires, floods, severe winter storms, severe dust storms, etc., may put people, property and animals at risk.

University of Missouri researchers have created the first-ever vaccine proven to protect cattle from bovine anaplasmosis, a tick-borne cattle disease. The disease infects the red blood cells of cattle and causes millions of dollars in economic losses across the U.S. due to reduced cattle production, treatment costs and animal deaths.